KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Inventory Average (2019 - 2025)

BioNTech SE's Inventory Average history spans 7 years, with the latest figure at $196.4 million for Q4 2025.

  • On a quarterly basis, Inventory Average fell 38.21% to $196.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $196.4 million, a 38.21% decrease, with the full-year FY2025 number at $213.9 million, down 37.78% from a year prior.
  • Inventory Average hit $196.4 million in Q4 2025 for BioNTech SE, down from $262.5 million in the prior quarter.
  • Over the last five years, Inventory Average for BNTX hit a ceiling of $10.5 billion in Q3 2021 and a floor of $48.6 million in Q1 2021.
  • Historically, Inventory Average has averaged $1.9 billion across 5 years, with a median of $399.4 million in 2023.
  • The widest YoY moves for Inventory Average: up 1020.66% in 2022, down 94.3% in 2022.
  • Tracing BNTX's Inventory Average over 5 years: stood at $6.5 billion in 2021, then tumbled by 94.3% to $372.9 million in 2022, then rose by 12.29% to $418.7 million in 2023, then decreased by 24.1% to $317.8 million in 2024, then crashed by 38.21% to $196.4 million in 2025.
  • Business Quant data shows Inventory Average for BNTX at $196.4 million in Q4 2025, $262.5 million in Q3 2025, and $264.4 million in Q2 2025.